Making recombinant proteins in animals - Different systems, different applications

Trends in Biotechnology

Volumn 21, Issue 9, 2003, Pages 394-399

  Dyck, Michael K ^a   Lacroix, Dan ^a   Pothier, François ^a   Sirard, Marc André ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOREACTORS; PROTEINS; TISSUE;

TRANSGENIC ANIMALS;

BIOTECHNOLOGY;

DNA; RECOMBINANT PROTEIN;

BIOTECHNOLOGY; GENETICALLY MODIFIED ORGANISM; PROTEIN;

ALGA; BACTERIUM; BACULOVIRUS EXPRESSION SYSTEM; BIOREACTOR; BIOTECHNOLOGY; CELL CULTURE; COST BENEFIT ANALYSIS; DNA BINDING; DNA MODIFICATION; DNA TRANSFECTION; FUNGUS; GENE EXPRESSION SYSTEM; GLYCOSYLATION; HUMAN; IMMUNOGENICITY; INSECT CELL; MAMMAL CELL; MAMMARY GLAND; METAZOON; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; REVIEW; SPERM; SWINE; TECHNIQUE; TRANSGENIC ANIMAL; TRANSGENIC PLANT; YEAST;

ALGAE; ANIMALIA; BACTERIA (MICROORGANISMS); FUNGI; INSECTA; MAMMALIA; METAZOA; SUS SCROFA; UNIDENTIFIED BACULOVIRUS;

EID: 0041887181     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(03)00190-2     Document Type: Review

References (81)

1. Dove A. Uncorking the biomanufacturing bottleneck. Nat. Biotechnol. 20:2002;777-779.
2. Werner R.G., et al. Appropriate mammalian expression systems for biopharmaceuticals. Arzneim.-Forsch. Drug Res. 48:1998;870-880.
3. Fischer R., et al. Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants. Biotechnol. Appl. Biochem. 30:1999;101-108.
4. Verma R., et al. Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. J. Immunol. Methods. 216:1998;165-181.
5. Morton C.L., Potter P.M. Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression. Application to a rabbit liver carboxylesterase. Mol. Biotechnol. 16:2000;193-202.
6. Bulleid N.J., et al. Recombinant expression systems for the production of collagen. Biochem. Soc. Trans. 28:2000;350-353.
7. Balbas P. Understanding the art of producing protein and nonprotein molecules in Escherichia coli. Mol. Biotechnol. 19:2001;251-267.
8. Collet J.F., Bardwell J.C. Oxidative protein folding in bacteria. Mol. Microbiol. 44:2002;1-8.
9. Swartz J.R. Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol. 12:2001;195-201.
10. Conesa A., et al. The secretion pathway in filamentous fungi: a biotechnological view. Fungal Genet. Biol. 33:2001;155-171.
11. Cregg J.M., et al. Recombinant protein expression in Pichia pastoris. Mol. Biotechnol. 16:2000;23-52.
12. Punt P.J., et al. Filamentous fungi as cell factories for heterologous protein production. Trends Biotechnol. 20:2002;200-206.
13. Fuhrmann M., et al. A synthetic gene coding for the green fluorescent protein (GFP) is a versatile reporter in Chlamydomonas reinhardtii. Plant J. 19:1999;353-361.
14. Farrell P.J., et al. Transformed Lepidopteran insect cells: new sources of recombinant human tissue plasminogen activator. Biotechnol. Bioeng. 64:1999;426-433.
15. Andersen D.C., Krummen L. Recombinant protein expression for therapeutic applications. Curr. Opin. Biotechnol. 13:2002;117-123.
16. Daniell H. Molecular farming for health - production of antibodies, biopharmaceuticals and edible vaccines in plants. Briefings W.M.S.B. Healthcare & Pharmaceutical Briefing - Life Sciences Technology. 2002;1-8 World Markets Research Center, London, UK.
17. Giddings G., et al. Transgenic plants as factories for biopharmaceuticals. Nat. Biotechnol. 18:2000;1151-1155.
18. Das, R.C. (2001) Production of therapeutic proteins from transgenic animals. In American Biotechnology Laboratory (Vol. Feb), pp. 60-64, International Science Communications, Shelton, Connecticut, USA.
19. Harvey A.J., et al. Expression of exogenous protein in the egg white of transgenic chickens. Nat. Biotechnol. 20:2002;396-399.
20. Rudolph N.S. Biopharmaceutical production in transgenic livestock. Trends Biotechnol. 17:1999;367-374.
21. Tomita M., et al. Transgenic silkworms produce recombinant human type III procollagen in cocoons. Nat. Biotechnol. 21:2003;52-56.
22. Eyestone W.H. Production and breeding of transgenic cattle using in vitro embryo production technology. Theriogenology. 51:1999;509-517.
23. Houdebine L.M. The production of pharmaceutical proteins from the milk of transgenic animals. Reprod. Nutr. Dev. 35:1995;609-617.
24. Wall R.J., et al. Transgenic dairy cattle: genetic engineering on a large scale. J. Dairy Sci. 80:1997;2213-2224.
25. Massoud M., et al. The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits. Reprod. Nutr. Dev. 36:1996;555-563.
26. Harvey A.J., et al. Expression of exogenous protein in the egg white of transgenic chickens. Nat. Biotechnol. 20:2002;396-399.
27. Swanson M.E., et al. Production of functional human hemoglobin in transgenic swine. Biotechnology. 10:1992;557-559.
28. Kerr D.E., et al. The bladder as a bioreactor: urothelium production and secretion of growth hormone into urine. Nat. Biotechnol. 16:1998;75-79.
29. Zbikowska H.M., et al. The use of the uromodulin promoter to target production of recombinant proteins into urine of transgenic animals. Transgenic Res. 11:2002;425-435.
30. Zbikowska H.M., et al. Uromodulin promoter directs high-level expression of biologically active human alpha1-antitrypsin into mouse urine. Biochem. J. 365:2002;7-11.
31. Ryoo Z.Y., et al. Expression of recombinant human granulocyte macrophage-colony stimulating factor (hGM-CSF) in mouse urine. Transgenic Res. 10:2001;193-200.
32. Dyck M.K., et al. Seminal vesicle production and secretion of growth hormone into seminal fluid. Nat. Biotechnol. 17:1999;1087-1090.
33. Setchell B.P., Brooks D.E. Anatomy, vasculature, innervation, and fluids of the male reproductive tract. Knobil E.A.N.J. The Physiology of Reproduction. Vol. 1:1988;753-836 Raven Press.
34. Anderson L.L. Pigs. Hafez E.S.E. Reproduction in Farm Animals. 1993;324-345 Lea & Febriger.
35. Solis D., et al. Binding of mannose-6-phosphate and heparin by boar seminal plasma PSP-II, a member of the spermadhesin protein family. FEBS Lett. 431:1998;273-278.
36. Wilkins T.D., Velander W. Isolation of recombinant proteins from milk. J. Cell. Biochem. 49:1992;333-338.
37. Gordon J.W., et al. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. U. S. A. 77:1980;7380-7384.
38. Hammer R.E., et al. Production of transgenic rabbits, sheep and pigs by microinjection. Nature. 315:1985;680-683.
39. Pinkert C.A., Murray J.D. Transgenic farm animals. Murray J.D., et al. Transgenic Animals in Agriculture. 1999;1-18 CABI.
40. Clark A.J., et al. Chromosomal position effects and the modulation of transgene expression. Reprod. Fertil. Dev. 6:1994;589-598.
41. Varmus H. Retroviruses. Science. 240:1988;1427-1435.
42. Friedrich G., Soriano P. Insertional mutagenesis by retroviruses and promoter traps in embryonic stem cells. Methods Enzymol. 225:1993;681-701.
43. Cepko C.L., et al. Lineage analysis with retroviral vectors. Methods Enzymol. 327:2000;118-145.
44. van der Putten H., et al. Efficient insertion of genes into the mouse germ line via retroviral vectors. Proc. Natl. Acad. Sci. U. S. A. 82:1985;6148-6152.
45. Rubenstein J.L., et al. Introduction of genes into preimplantation mouse embryos by use of a defective recombinant retrovirus. Proc. Natl. Acad. Sci. U. S. A. 83:1986;366-368.
46. Haskell R.E., Bowen R.A. Efficient production of transgenic cattle by retroviral infection of early embryos. Mol. Reprod. Dev. 40:1995;386-390.
47. Chan A.W., et al. Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14028-14033.
48. Lavitrano M., et al. Sperm cells as vectors for introducing foreign DNA into eggs: genetic transformation of mice. Cell. 57:1989;717-723.
49. Lavitrano M., et al. Sperm-mediated gene transfer: production of pigs transgenic for a human regulator of complement activation. Transplant. Proc. 29:1997;3508-3509.
50. Lavitrano M., et al. Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation. Proc. Natl. Acad. Sci. U. S. A. 99:2002;14230-14235.
51. Lavitrano M., et al. Sperm mediated gene transfer in pig: selection of donor boars and optimization of DNA uptake. Mol. Reprod. Dev. 64:2003;284-291.
52. Bachiller D., et al. Liposome-mediated DNA uptake by sperm cells. Mol. Reprod. Dev. 30:1991;194-200.
53. Gagne M.B., et al. Electroporation of bovine spermatozoa to carry foreign DNA in oocytes. Mol. Reprod. Dev. 29:1991;6-15.
54. Horan R., et al. Association of foreign DNA with porcine spermatozoa. Arch. Androl. 26:1991;83-92.
55. Chang K., et al. Effective generation of transgenic pigs and mice by linker based sperm-mediated gene transfer. BMC Biotechnol. 2:2002;5.
56. Brinster R.L., et al. No simple solution for making transgenic mice. Cell. 59:1989;239-241.
57. Brinster R.L. Germline stem cell transplantation and transgenesis. Science. 296:2002;2174-2176.
58. Brinster R.L., Zimmermann J.W. Spermatogenesis following male germ-cell transplantation. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11298-11302.
59. Brinster R.L., Avarbock M.R. Germline transmission of donor haplotype following spermatogonial transplantation. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11303-11307.
60. Dym M. Spermatogonial stem cells of the testis. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11287-11289.
61. Brinster R.L., Nagano M. Spermatogonial stem cell transplantation, cryopreservation and culture. Semin. Cell Dev. Biol. 9:1998;401-409.
62. Kim J.H., et al. Development of a positive method for male stem cell-mediated gene transfer in mouse and pig. Mol. Reprod. Dev. 46:1997;515-526.
63. Honaramooz A., et al. Use of adeno-associated virus for trasfection of male-germ cells for transplantation in pigs. Theriogenology. 59:2003;536.
64. Fassler R., et al. Knockout mice: how to make them and why. The immunological approach. Int. Arch. Allergy Immunol. 106:1995;323-334.
65. Galli-Taliadoros L.A., et al. Gene knock-out technology: a methodological overview for the interested novice. J. Immunol. Methods. 181:1995;1-15.
66. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature. 292:1981;154-156.
67. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 78:1981;7634-7638.
68. Giles J.R., et al. Pluripotency of cultured rabbit inner cell mass cells detected by isozyme analysis and eye pigmentation of fetuses following injection into blastocysts or morulae. Mol. Reprod. Dev. 36:1993;130-138.
69. Wheeler M.B. Development and validation of swine embryonic stem cells: a review. Reprod. Fertil. Dev. 6:1994;563-568.
70. Iwasaki S., et al. Production of live calves derived from embryonic stem-like cells aggregated with tetraploid embryos. Biol. Reprod. 62:2000;470-475.
71. Petitte J.N., et al. Production of somatic and germline chimeras in the chicken by transfer of early blastodermal cells. Development. 108:1990;185-189.
72. Anderson G.B. Embryonic stem cells in agriculture. Murray J.D., et al. Transgenic Animals in Agriculture. 1999;59-66 CABI.
73. Bacon L.D., et al. Identrification and evaluation of major histocompatibility complex antigens in chicken chimeras and their relationship to germline transmission. Poultry Sci. 81:2002;1427-1438.
74. Schnieke A.E., et al. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science. 278:1997;2130-2133.
75. Cibelli J.B., et al. Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells. Nat. Biotechnol. 16:1998;642-646.
76. Cibelli J.B., et al. Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science. 280:1998;1256-1258.
77. Lai L., et al. Transgenic pig expressing the enhanced green fluorescent protein produced by nuclear transfer using colchicine-treated fibroblasts as donor cells. Mol. Reprod. Dev. 62:2002;300-306.
78. Robl J.M., et al. Artificial chromosome vectors and expression of complex proteins in transgenic animals. Theriogenology. 59:2003;107-113.
79. Hill J.R., et al. Clinical and pathologic features of cloned transgenic calves and fetuses (13 case studies). Theriogenology. 51:1999;1451-1465.
80. Cibelli J.B., et al. The health profile of cloned animals. Nat. Biotechnol. 20:2002;13-14.
81. Pursel V.G., et al. Expression and performance in transgenic pigs. J. Reprod. Fertil. Suppl. 40:1990;235-245.